Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods and compositions for analyte detection

a technology of analyte and composition, applied in the field of analyte detection, can solve the problems of epidemics, false positives can also be troublesome, and the techniques have not solved all the problems encountered, so as to prevent reading

Inactive Publication Date: 2015-11-12
NEXUS DX
View PDF9 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The system offers high sensitivity with fewer false positives, enabling rapid and reliable detection of infectious agents, including influenza strains and subtypes, with results that can be read within minutes to several hours, suitable for both laboratory and point-of-care settings.

Problems solved by technology

False positives can also be troublesome, particularly with agglutination and other rapid detection methods such as dipstick and color change tests.
These techniques have not solved all of the problems encountered in these rapid detection methods.
Epidemics may appear at any time and can occur explosively with little or no warning.
Although influenza is a mild disease in most individuals, it is life threatening to elderly, the very young or debilitated individuals.
Epidemics are responsible for large losses in productivity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and compositions for analyte detection
  • Methods and compositions for analyte detection
  • Methods and compositions for analyte detection

Examples

Experimental program
Comparison scheme
Effect test

example 1

Assay Volume and Chasing Buffer

[0339]To explore the optimal assay sample volume that will give the best sensitivity and to investigate if a chasing buffer will also increase the sensitivity and performance of the test strip.

[0340]Materials: Nitrocellulose Membrane: Millipore HiFlow 135 membrane, 2.5 cm in width. Cat. No. SHF1350425, Lot No. R68N46849, Code No. RK04414, roll No. 040L1. Membrane was striped with monoclonal anti-H5N1 antibody, clone 3C8 at 1.0 mg / ml. Control line was striped with 1.5 mg / m1 rabbit anti-mouse antibody. Wicking pad: 0.05% Tween-20 treated polyester pad. Alhstrom grade 6613. Prepared Absorbent pad: Ahlstrom Grade 222 paper, 3.5 cm in width, purchased from Fisher, Cat. #2228-1212, lot #6150502. Anti-H5 3G4 gold conjugate was prepared by Nanogen POC at Toronto, Canada, OD of 3G4 gold conjugate at maximal absorbent peak was 112.54. Extraction buffer: 50 mM Tris-Cl, pH 8.15, 0.75 M NaCl, 1% BSA, 0.1% plutonic F68, 0.05% digested casein, 2 mM TCEP and 0.02% NaN...

example 2

Europium Bead Versus Prior Art System

[0350]Materials: Inactivated influenza A virus: Texas 1 / 77 (H3N2) from Microbix Biosystems, Inc. Cat. #EL-13-02, lot #13037A3; Inactivated influenza B virus: Hong Kong 5 / 72 from Microbix Biosystems, Inc. Cat. #EL-14-03, lot #14057A2; Quidel QuickVue A+B Test, lot #702391

[0351]Protocol: Virus dilution-Influenza A and influenza B viral preparations were diluted with saline to 4096 HA / mL and 409.6 HA / mL, respectively, before use. Assay procedure: Procedures described in the package insert of the Quidel test kit were followed and briefly reviewed here. Dispense all of the Extraction Reagent Solution from the reagent tube. Gently swirl the tube to dissolve its content. Spike virus into the tube. Place the swab into the Extraction Tube. Roll the swab at least three times while pressing the head against the bottom and side of the Extraction Tube. Leave the swab in the tube for 1 min. Roll the swab head against the inside of the tube as you remove it. Pl...

example 3

Test the Detection Limit of Influenza A and B Test Using Gold Label

[0357]Materials: Anti-Flu A M4090913 gold conjugate was prepared by Nanogen POC at Toronto, Canada. OD was 102.69 at maximal absorbent peak. Anti-Flu B antibody 2 / 3 gold conjugate was prepared by Nanogen POC at Toronto, Canada. OD was 94.78 at maximal absorbent peak. See above for nitrocellulose membrane, wicking pad and absorbent pad. Membrane striped with anti-Flu B M2110171 antibody at 1.5 mg / ml and rabbit anti-mouse antibody at 1.5 mg / ml was prepared by Nanogen POC at Toronto, Canada. Membrane striped with anti-Flu A 7304 antibody at 1.5 mg / ml and rabbit anti-mouse antibody at 1.5 mg / ml was prepared by Nanogen POC at Toronto, Canada. Inactivated influenza A H3N2, Texas 1 / 77 was purchased from Microbix Biosystems, Inc. lot #13037A3, 40960 HA / mL.

[0358]Inactivated influenza B, Hong Kong 5 / 72 was purchased from Microbix, Biosystems, Inc., lot #14057A2, 40960 HA / mL; Molecular Biology Water, lot #318105; 3× extraction ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
pore diameteraaaaaaaaaa
Login to View More

Abstract

The present invention is directed to methods and apparatus for detection of one or more analytes. Analytes include agents or components of infectious agents such as pathogenic virus, as well as enzymes, proteins and biomarkers.

Description

RELATED APPLICATIONS[0001]This application claims priority to U.S. provisional application No. 60 / 775,649, filed Feb. 21, 2006, No. 60 / 789,345, filed Apr. 5, 2006, and No. 60 / 866,932 filed Nov. 22, 2006, pursuant 35 U.S.C. 119(e), and the disclosure for each of which is incorporated by reference herein in its entirety.STATEMENT AS TO GOVERNMENT SUPPORTED RESEARCH[0002]Portions of this invention may have been made with the support of the United States government under contract number 200-2007-19345 granted by the Center for Disease Control. The Government may have certain rights to portions of this invention.BACKGROUND OF THE INVENTION[0003]This invention relates to assays for analyte(s), e.g., antigens, in a sample such as a biological sample obtained from an animal. In particular, the invention relates to a method and device(s) for the detection of an analyte(s) utilizing binding moieties specifically targeting a selected analyte. More particularly, the analytes to be detected incl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): G01N33/569
CPCG01N33/56983G01N2469/10G01N2333/11B01L3/5023B01L3/5029B01L2300/0636B01L2300/0681B01L2300/0816B01L2300/0832B01L2300/087B01L2400/0478B01L2400/0683C12Q1/701Y10S435/81Y10S436/808Y10S436/81G01N33/54388
Inventor EGAN, RICHARD LASWELLLIDGARD, GRAHAM PETERBOOKER, DAVID DICKSONJOHNSON, CHRISTOPHER JOHANN
Owner NEXUS DX